FullSizeRender (6)

mClinica continues its rapid expansion across Southeast Asia with country launch at 9th Thailand Pharmacy Congress

On November 17 and 18, a delegation from mClinica launched country operations in Thailand at the 9th Thailand Pharmacy Congress at the Bangkok International Trade and Exhibition Centre (BITEC) in Bangkok, Thailand. There could not have been a more appropriate setting for mClinica’s Thailand launch than at this year’s congress, themed “Smart Aging Life and Digital Pharmacy 4.0.” How mClinica is unifying pharmacists is clear: Since its launch at the beginning of this year, SwipeRx has become the leading platform for pharmacy professionals across Southeast Asia, counting more than 55,000 devoted users. In Cambodia and Indonesia, 1 in every 4


mClinica marks success of SwipeRx with delegation at the Asian Young Pharmacy Group (AYPG) Leadership Summit 2017

From November 11 to November 13, 2017, pharmacists from all across Asia converged onto the International Medical University (IMU) campus in Kuala Lumpur, Malaysia for the Asian Young Pharmacist Group’s Leadership Summit 2017. The summit is the largest annual gathering for young pharmacists in the region, and this year’s summit featured a delegation from mClinica, led by founder and CEO Farouk Meralli along with COO Vasil Rusinov. mClinica’s participation in the summit could not have come at a more fitting time: SwipeRx, its mobile app, recently became the largest online community for pharmacy professionals in Asia after its launch earlier

Screen Shot 2017-10-27 at 1.09.56 AM

Harvard University honors mClinica CEO Farouk Meralli with the Public Health Innovator Award for his work transforming public health in Southeast Asia

On Saturday, October 14, 2017, mClinica founder and CEO Farouk Meralli was honored by Harvard T.H. Chan School of Public Health during its Alumni Association Awards with its Public Health Innovator Award. Meralli graduated from Harvard in 2009 and returned to this event as the youngest recipient in the award’s history at only 31 years of age. The Public Health Innovator was one of only three mid-career awards given at the Alumni Association Awards. The other two awardees were Henry-Jen Su, the president and distinguished professor from National Cheng Kung University in Taiwan, who received a Leadership Award in Public

Screen Shot 2017-10-09 at 8.55.54 AM

Public Health Alert: Study says Filipino patients under-treatment with antibiotics

What’s happening? According to a recent study by mClinica, the vast majority of patients in the Philippines are buying fewer than the amount of antibiotics they were prescribed. The exact numbers are staggering. On average, patients are prescribed 21 antibiotic pills. Approximately one-half of patients are only buying between 1 to 6 pills, while 22% are purchasing between 7 to 13 pills. The last demographic at 27% is buying 14 to 21 pills. Only 1% of the population are buying more than 21 antibiotic pills.   Why does this matter? The amount of pills that a doctor writes on a prescription

Tuberculosis Case Study

World Tuberculosis Day: A Call To Action

WHAT IS TUBERCULOSIS? Tuberculosis or “TB” is a treatable contagious disease that usually infects the lungs. It is caused by Mycobacterium tuberculosis bacilli and it can also be seen in the brain, skin, and other body organs. It is prevalent in densely populated countries such as China, India, Indonesia, and the Philippines. WHAT’S GOING ON HERE? The World Health Organization (WHO) recommends combination therapy of 2-4 drugs as the gold standard treatment for TB over a period of six months. mClinica’s data in 2016 revealed that in the Philippines and Indonesia, the percentage of transactions consisting of single drug or